---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-058626"
form_type: "8-K"
ticker: null
cik: "0000811240"
company_name: "BIOLASE, INC"
filed_at: "2024-05-13T23:59:59+00:00"
generated_at: "2026-06-02T03:01:38.701586+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# BIOLASE Q1 net revenue $10.1M (down 3% YoY); reiterates FY2024 guidance

## Summary
- Net revenue $10.1M, down 3% YoY; U.S. laser revenue down 22% to $2.7M.
- Gross margin improved to 33% (up 1 ppt YoY); operating loss narrowed 15% to $4.5M.
- Consumables revenue up 14% YoY; third strongest consumables quarter in company history.
- Adjusted EBITDA loss improved 21% to $3.5M ($0.20 per share) vs. $4.4M a year ago.
- Reaffirms FY2024 guidance: revenue $52-53M (6-8% growth) and positive Adjusted EBITDA.

## SEC filing metadata
- accession: 0000950170-24-058626
- form_type: 8-K
- cik: 0000811240
- company_name: BIOLASE, INC
- filed_at: 2024-05-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/811240/000095017024058626/0000950170-24-058626-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/811240/000095017024058626/biol-20240513.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-058626
- JSON: https://secwatch.observer/filing/0000950170-24-058626.json
- Plain text: https://secwatch.observer/filing/0000950170-24-058626.txt

## Key facts
- Earnings Releases
  BIOLASE, INC reported first quarter ended March 31, 2024 results: revenue $10.1 million. Guidance reaffirmed.
  - Period: first quarter ended March 31, 2024
  - Revenue: $10.1 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: resources necessary to maximize our growth opportunities and to enhance shareholder value.” First Quarter Financial Results Net revenue for the quarter ended March 31, 2024, was $10.1 million, a decrease of 3% compared to net revenue of $10.5 million for the quarter ended March 31, 2023. U.S. laser revenue was $2.7 million for the quarter ended March 31, 2024, a
  evidence_url: https://www.sec.gov/Archives/edgar/data/811240/000095017024058626/0000950170-24-058626-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.